Skip to content

Clinical Research of Shuxin Anshen Paste on Chronic Insomnia

Clinical Research of Shuxin Anshen Paste on Chronic Insomnia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-17010539
Enrollment
Unknown
Registered
2017-02-01
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

Treatment Group:Shu Xin An Shen Paste

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Be diagnosed as chronic insomnia according to the Diagnostic criteria for the third edition of the international classification of sleep disorders (ICSD-3); 2. Aged 18-75 years old; 3. People who has good compliance and accepts the study and signed the written informed consent form for the clinical trial.

Exclusion criteria

Exclusion criteria: 1. Diagnoses of other sleep disorders such as obstructive sleep apnea syndrome or restless legs syndrome; 2. Insomnia combined with acute or chronic diseases such as cardiovascular diseases, cerebrovascular diseases, inflammatory diseases, tumors, infectious diseases or so on that maybe influence persons sleep or immunologic function, people with severe hepatic or renal dysfunction; 3. Has a severe psychiatric disorder of major psychiatric disorder (for example, depression, anxiety and so on); 4. Taking anti-inflammatory agent, antidepressants, antipsychotics or medications for insomnia within a week; 5. Women during pregnancy or lactation; 6. Not suitable for the study by a physician's evaluation.

Design outcomes

Primary

MeasureTime frame
Polysomnography;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
TCM Syndromes Scale;

Countries

China

Contacts

Public ContactXu Fuping

Guangdong Provincial Hospital of Chinese Medicine

xufuping163@163.com+86 15902042439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026